Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,760.00
(
-0.15%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.43
(
-2.02%
)
Bitcoin
70,438.33
(
-1.13%
)
News Focus
News Focus

Replies to post #164447 on Biotech Values

Replies to #164447 on Biotech Values
icon url

DewDiligence

07/25/13 9:13 AM

#164448 RE: genisi #164447

There’s something seriously wrong with only $12M of Eliquis sales. This will probably be #1 topic on BMY CC at 10:30am ET.
icon url

DewDiligence

07/25/13 9:18 AM

#164449 RE: genisi #164447

BMY cut 2013 (non-GAAP) EPS guidance to $1.70-1.78 (from prior range of $1.78-1.88) based on revenue of $16B (down from prior guidance of $16.5B).
icon url

DewDiligence

07/25/13 10:45 AM

#164454 RE: genisi #164447

Orencia could soon become BMY’s biggest-selling drug. 2Q13 sales were $352M, +21% YoY (http://finance.yahoo.com/news/bristol-myers-squibb-reports-second-113000028.html ).